Evidence map›Paper›PMID 35465230›Full record

ArticlePatterns (New York, N.Y.)2022

Machine vision-assisted identification of the lung adenocarcinoma category and high-risk tumor area based on CT images.

Liuyin Chen, Haoyang Qi, Di Lu, Jianxue Zhai, Kaican Cai, Long Wang, Guoyuan Liang, Zijun Zhang

Abstract read
In one paragraph

Article in Patterns (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liuyin ChenSchool of Data Science, City University of Hong Kong, Hong Kong SAR, China.
Haoyang QiSchool of Data Science, City University of Hong Kong, Hong Kong SAR, China.
Di LuDepartment of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jianxue ZhaiDepartment of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Kaican CaiDepartment of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Long WangDepartment of Computer Science and Technology, University of Science and Technology Beijing, Beijing, China.
Guoyuan LiangShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Zijun ZhangSchool of Data Science, City University of Hong Kong, Hong Kong SAR, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computed tomography (CT) is a widely used medical imaging technique. It is important to determine the relationship between CT images and pathological examination results of lung adenocarcinoma to better support its diagnosis. In this study, a bilateral-branch network with a knowledge distillation procedure (KDBBN) was developed for the auxiliary diagnosis of lung adenocarcinoma. KDBBN can automatically identify adenocarcinoma categories and detect the lesion area that most likely contributes to the identification of specific types of adenocarcinoma based on lung CT images. In addition, a knowledge distillation process was established for the proposed framework to ensure that the developed models can be applied to different datasets. The results of our comprehensive computational study confirmed that our method provides a reliable basis for adenocarcinoma diagnosis supplementary to the pathological examination. Meanwhile, the high-risk area labeled by KDBBN highly coincides with the related lesion area labeled by doctors in clinical diagnosis.

Indexed as

convolutional neural networksCT image analyticsdeep learninglung cancerpathological diagnosis

Identifiers

PMID35465230
PMCPMC9024012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.